Search

Your search keyword '"Tellini, Riccardo"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Tellini, Riccardo" Remove constraint Author: "Tellini, Riccardo" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
37 results on '"Tellini, Riccardo"'

Search Results

1. Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group

2. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)

4. A Nomogram for the Prediction of Intermediate Significant Renal Function Loss After Robot-assisted Partial Nephrectomy for Localized Renal Tumors: A Prospective Multicenter Observational Study (RECORd2 Project)

5. A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)

6. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project)

7. Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): Analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework

9. Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden

10. Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden

11. Patterns and Predictors of Optimal Surgical and Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introducing the Concept of “Trifecta”

12. Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81]

13. Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer

14. Analysis of molecular and clinical markers of resistance to bacillus of Calmette-Guérin immunotherapy in patients with urothelial non-muscle invasive bladder cancer

16. Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry

17. Assessing the impact of socio‐economic determinants on access to care, surgical treatment options and outcomes among patients with renal mass: Insight from the universal healthcare system

18. Robotic vs Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair “tetrafecta” Analysis (ROBUUST Collaborative Group)

19. PD15-06 ELEVATED HEMOGLOBIN:CREATININE RATIO IS A NOVEL PREOPERATIVE MARKER FOR WORSENED SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS FROM THE ROBUUST REGISTRY

20. PD58-11 IMPACT OF PRE-OPERATIVE KIDNEY FUNCTION ON SURVIVAL OUTCOMES IN UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY

21. PD58-07 IMPACT OF NODE COUNT ON SURVIVAL OUTCOMES OF LYMPH NODE DISSECTION IN NON-METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: ANALYSIS OF THE ROBUUST REGISTRY

22. MP40-11 RENAL FUNCTION VARIATION AFTER NEPHROURETERECTOMY FOR UPPER URINARY TRACT CARCINOMA: EVALUATION IN A LARGE MULTICENTER COHORT (RADICAL NEPHROURETERECTOMY OUTCOMES (RANEO) RESEARCH CONSORTIUM)

23. Robotic surgery for ureteropelvic junction obstruction and urolithiasis

24. Corrigendum re “A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)” [Eur Urol Focus 2022;8:173–81]

26. Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort

28. sj-pdf-1-tau-10.1177_17562872221090884 – Supplemental material for Robot-assisted sacro(hystero)colpopexy with anterior and posterior mesh placement: impact on lower bowel tract function and clinical outcomes at mid-term follow-up

29. Robot-assisted sacro(hystero)colpopexy with anterior and posterior mesh placement: impact on lower bowel tract function and clinical outcomes at mid-term follow-up

31. Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal Cancer Care

33. Impact of the Treatment of Serenoa repens, Solanum lycopersicum, Lycopene and Bromelain in Combination with Alfuzosin for Benign Prostatic Hyperplasia. Results from a Match-Paired Comparison Analysis

34. En-Bloc Holmium Laser Enucleation of the Prostate with Early Apical Release: Are We Ready for a New Paradigm?

35. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)

36. Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini’s nomogram on the RECORD2 project cohort

37. Holmium laser enucleation of the prostate (HoLEP) is safe and effective in patients with high comorbidity burden.

Catalog

Books, media, physical & digital resources